79 NDCs across 23 manufacturers|68 Generic,11 Brand
Carbamazepine is used to treat bipolar disorder, complex partial epilepsy, tonic-clonic epilepsy, psychotic disorders, restless legs syndrome and schizophrenia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved May 15, 1986. FDA's Orange Book lists 68 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $128 million on Carbamazepine across 1.3 million claims for 229,000 beneficiaries.
Carbamazepine is available as 79 NDCs from 23 manufacturers (68 generic, 11 brand), with NADAC prices from $0.12 to $6.49 per EA — the most expensive product costs about 55× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
79
68G / 11B
Manufacturers
23
competing in market
Price Spread
$0.12 – $6.49
per EA, 75 of 79 NDCs
7d Activity
61↑4↓13 flat
avg +3.8% WoW · of 79 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Carbamazepine is used to treat bipolar disorder, complex partial epilepsy, tonic-clonic epilepsy, psychotic disorders, restless legs syndrome and schizophrenia, per the National Library of Medicine's MED-RT classification.
When did Carbamazepine become available as a generic?
FDA approved the first generic Carbamazepine (ANDA) on May 15, 1986. The Orange Book currently lists 68 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Carbamazepine?
In 2024, Medicare Part D spent $128 million on Carbamazepine across 1.3 million claims for 229,000 beneficiaries.
How many Carbamazepine products are on the market?
The Carbamazepine drug market contains 79 NDCs from 23 manufacturers — 68 generic and 11 brand products.
What is the price range for Carbamazepine?
NADAC reference prices for Carbamazepine range from $0.1170 to $6.4891 per EA — the most expensive product costs about 55× the cheapest. 4 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Carbamazepine cheaper than brand?
The average generic NADAC for Carbamazepine is $0.4058 per EA, versus $3.1997 for brand-labeled products — brand versions average about 7.9× the generic price.
Which manufacturers make Carbamazepine?
23 manufacturers list Carbamazepine in NADAC. Ranked by number of NDCs, the largest are Sun Pharmaceutical Industries Inc. (9), Torrent Pharmaceuticals Limited (8), Novartis Pharmaceuticals Corporation (5), Apotex Corp. (5), Major Pharmaceuticals (4).
How has the price of Carbamazepine changed recently?
Over the past 7 days, 61 Carbamazepine NDCs rose and 4 fell, with a market-wide average change of +3.8%.